Applied Microarrays, Inc., headquartered in the United States, is a leading player in the biotechnology industry, specialising in microarray technology and genomic solutions. Founded in 2001, the company has established itself as a pioneer in the development of high-quality microarray products and services, catering to a diverse range of applications in research and diagnostics. With a focus on custom microarray design and manufacturing, Applied Microarrays offers unique solutions that enable researchers to conduct comprehensive genomic analyses. Their innovative products, including the Array-on-Demand™ platform, stand out for their flexibility and precision, allowing for tailored applications across various fields, including cancer research and personalised medicine. Recognised for its commitment to quality and customer service, Applied Microarrays has solidified its market position, serving clients globally and contributing significantly to advancements in genomic research.
How does Applied Microarrays, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Applied Microarrays, Inc.'s score of 21 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Applied Microarrays, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Schott AG, which is at cascade level 2 in their corporate family relationship. Consequently, any climate commitments or emissions data may be influenced by Schott AG's initiatives. As of now, Applied Microarrays, Inc. has not established any documented reduction targets or climate pledges. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy. In the context of the industry, it is essential for companies like Applied Microarrays, Inc. to align with broader climate commitments and targets set by their parent organisation, Schott AG, which may include science-based targets and sustainability initiatives. However, without specific data or commitments from Applied Microarrays, Inc., it is challenging to assess their individual impact on carbon emissions and climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | - | - | - |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Applied Microarrays, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.